MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint InhibitorsBin Yang, Gang Chen|Cancer Research|2021Cited by 53
LncRNA DLX6‐AS1 increases the expression of HIF‐1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR‐199a‐5pBin Yang, Tao Xie|Molecular Genetics & Genomic Medicine|2019Cited by 30